Arch Biopartners Inc. Logo

Arch Biopartners Inc. (8HA)

FSX

Currency in EUR
0.5970
-0.05 (-7.87%)

Closed

Aug 26, 2026

Day's Range

0.5970
0.5970

52 wk Range

0.2495
0.7450

Overview - 8HA - Arch Biopartners Inc.

Key Statistics

Valuation

Enterprise Value

28.66M

P/E (Trailing)

‪-24.87‬

PEG Ratio

‪1.11‬

Price / Sales (TTM)

‪256.55‬

Price / Book

‪-10.96‬

EV / EBITDA

‪-23.08‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-1,418.63%‬

Return on Assets

‪-276.77%‬

Return on Equity

‪40.00%‬

Ownership

Shares Outstanding

67.72M

Float

53.52M

Held by Insiders

‪18.29%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪1.72‬

50-Day Avg

‪0.5034‬

200-Day Avg

‪0.4440‬

Dividends

Payout Ratio

‪0.00%‬

Peers - 8HA - Arch Biopartners Inc.

Peer Comparison

Compared with companies in Biotechnology listed on FSX.

Profile Summary - 8HA - Arch Biopartners Inc.

About

Arch Biopartners Inc. is a Canadian therapeutic biotechnology company focused on developing novel drug candidates to prevent and treat kidney-related injury and disease. Headquartered in Toronto, it concentrates on both acute kidney injury and chronic kidney disease, conditions that represent a significant burden in…

SectorHealthcare
IndustryBiotechnology
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.